A recent study showed that treating decidual MSCs derived from preeclampsia women with an ALDH1A1 activator restored ALDH1A1 activity and improved H2O2-induced oxidative stress resistance in preeclampsia-derived MSCs [47]. The gene discussed is ALDH1A1; the disease is preeclampsia.